Amendment: SEC Form SC 13G/A filed by MiMedx Group Inc
$MDXG
Biotechnology: Pharmaceutical Preparations
Health Care
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/2/2024 | $11.00 | Overweight | Cantor Fitzgerald |
3/7/2024 | $12.00 | Buy | Lake Street |
10/27/2023 | $12.00 | Buy | Craig Hallum |
10/13/2022 | $7.00 | Buy | Mizuho |
9/14/2021 | $20.00 → $8.50 | Buy | HC Wainwright & Co. |
7/26/2021 | $23.00 | Outperform | Northland Capital |